ID 4F64A STANDARD; PRT; 309 AA. DT CONVERTED FROM PDB (SEQRES) 4F64 DE Fibroblast growth factor receptor 1 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.050 CC R-Factor 0.217 FT #SUB 246 702 PRO A 248 704 VAL B Protein B 1 FT #SUB 246 702 PRO A 256 712 LEU B Protein B 1 FT #SUB 247 703 GLY A 248 704 VAL B Protein B 2 FT #SUB 247 703 GLY A 249 705 PRO B Protein B 1 FT #SUB 247 703 GLY A 252 708 GLU B Protein B 3 FT #SUB 248 704 VAL A 246 702 PRO B Protein S 1 FT #SUB 248 704 VAL A 247 703 GLY B Protein A 4 FT #SUB 248 704 VAL A 248 704 VAL B Protein S 1 FT #SUB 249 705 PRO A 247 703 GLY B Protein S 1 FT #SUB 249 705 PRO A 249 705 PRO B Protein S 1 FT #SUB 252 708 GLU A 247 703 GLY B Protein S 4 FT #SUB 261 717 HIS A 246 702 PRO B Protein S 1 FT #SUB 265 721 LYS A 267 723 SER B Protein A 3 FT #SUB 266 722 PRO A 267 723 SER B Protein B 1 FT #SUB 267 723 SER A 265 721 LYS B Protein S 6 FT #SUB 267 723 SER A 266 722 PRO B Protein S 1 FT #HET 28 484 LEU A 1 801 0S8 A A 10 FT #HET 36 492 VAL A 1 801 0S8 A S 3 FT #HET 56 512 ALA A 1 801 0S8 A S 3 FT #HET 58 514 LYS A 1 801 0S8 A S 1 FT #HET 75 531 GLU A 2 802 EDO A S 6 FT #HET 79 535 MET A 2 802 EDO A S 2 FT #HET 83 539 GLY A 4 804 SO4 A B 2 FT #HET 84 540 LYS A 4 804 SO4 A A 9 FT #HET 105 561 VAL A 1 801 0S8 A S 3 FT #HET 106 562 GLU A 1 801 0S8 A B 4 FT #HET 107 563 TYR A 1 801 0S8 A A 4 FT #HET 108 564 ALA A 1 801 0S8 A A 8 FT #HET 109 565 SER A 1 801 0S8 A B 2 FT #HET 111 567 GLY A 1 801 0S8 A B 2 FT #HET 171 627 ARG A 1 801 0S8 A B 1 FT #HET 174 630 LEU A 1 801 0S8 A S 6 FT #HET 184 640 ALA A 2 802 EDO A A 3 FT #HET 185 641 ASP A 2 802 EDO A B 8 FT #HET 186 642 PHE A 2 802 EDO A A 6 FT #HET 187 643 GLY A 2 802 EDO A B 3 FT #HET 228 684 TRP A 3 803 EDO A S 6 FT #HET 245 701 TYR A 3 803 EDO A S 7 FT #HET 257 713 LEU A 3 803 EDO A S 1 FT #HET 262 718 ARG A 3 803 EDO A A 4 FT #HET 263 719 MET A 3 803 EDO A A 5 FT #HET 281 737 TRP A 3 803 EDO A S 11 FT DISORDER 1 7 FT DISORDER 30 34 FT DISORDER 45 48 FT DISORDER 124 135 FT DISORDER 307 309 CC Miss-BB 1 CC Miss-SC 1 CC SEQUENCE 278 AA (ATOM); CC ELPEDPRWEL PRDRLVLGKP LGQVVLAEAI GLPNRVTKVA VKMLKSDATE KDLSDLISEM CC EMMKMIGKHK NIINLLGACT QDGPLYVIVE YASKGNLREY LQARRPPEEQ LSSKDLVSCA CC YQVARGMEYL ASKKCIHRDL AARNVLVTED NVMKIADFGL ARDIHHIDYY KKTTNGRLPV CC KWMAPEALFD RIYTHQSDVW SFGVLLWEIF TLGGSPYPGV PVEELFKLLK EGHRMDKPSN CC CTNELYMMMR DCWHAVPSQR PTFKQLVEDL DRIVALTS CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN CC ATOM -------ELPEDPRWELPRDRLVLGKPLG-----QVVLAEAIGL----PN CC ********************** ********** ** CC SEQRES RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP CC ATOM RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP CC ************************************************** CC SEQRES LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ CC ATOM LYVIVEYASKGNLREYLQARRPP------------EEQLSSKDLVSCAYQ CC *********************** *************** CC SEQRES VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK CC ATOM VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK CC ************************************************** CC SEQRES TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV CC ATOM TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV CC ************************************************** CC SEQRES EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR CC ATOM EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR CC ************************************************** CC SEQRES IVALTSNQE CC ATOM IVALTS--- CC ****** SQ SEQUENCE 309 AA; MW; CN; GAGVSEYELP EDPRWELPRD RLVLGKPLGE GAFGQVVLAE AIGLDKDKPN RVTKVAVKML KSDATEKDLS DLISEMEMMK MIGKHKNIIN LLGACTQDGP LYVIVEYASK GNLREYLQAR RPPGLEYSYN PSHNPEEQLS SKDLVSCAYQ VARGMEYLAS KKCIHRDLAA RNVLVTEDNV MKIADFGLAR DIHHIDYYKK TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL GGSPYPGVPV EELFKLLKEG HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR IVALTSNQE // ID 4F64B STANDARD; PRT; 309 AA. DT CONVERTED FROM PDB (SEQRES) 4F64 DE Fibroblast growth factor receptor 1 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.050 CC R-Factor 0.217 FT #SUB 246 702 PRO B 248 704 VAL A Protein B 1 FT #SUB 246 702 PRO B 261 717 HIS A Protein S 1 FT #SUB 247 703 GLY B 248 704 VAL A Protein B 4 FT #SUB 247 703 GLY B 249 705 PRO A Protein B 1 FT #SUB 247 703 GLY B 252 708 GLU A Protein B 4 FT #SUB 248 704 VAL B 246 702 PRO A Protein S 1 FT #SUB 248 704 VAL B 247 703 GLY A Protein A 2 FT #SUB 248 704 VAL B 248 704 VAL A Protein S 1 FT #SUB 249 705 PRO B 247 703 GLY A Protein S 1 FT #SUB 249 705 PRO B 249 705 PRO A Protein S 1 FT #SUB 252 708 GLU B 247 703 GLY A Protein S 3 FT #SUB 256 712 LEU B 246 702 PRO A Protein S 1 FT #SUB 265 721 LYS B 267 723 SER A Protein A 6 FT #SUB 266 722 PRO B 267 723 SER A Protein B 1 FT #SUB 267 723 SER B 265 721 LYS A Protein S 3 FT #SUB 267 723 SER B 266 722 PRO A Protein S 1 FT #HET 28 484 LEU B 5 801 0S8 B A 7 FT #HET 36 492 VAL B 5 801 0S8 B S 2 FT #HET 56 512 ALA B 5 801 0S8 B S 3 FT #HET 58 514 LYS B 5 801 0S8 B S 1 FT #HET 75 531 GLU B 5 801 0S8 B S 1 FT #HET 75 531 GLU B 6 802 EDO B S 4 FT #HET 79 535 MET B 6 802 EDO B S 1 FT #HET 89 545 ILE B 6 802 EDO B S 2 FT #HET 105 561 VAL B 5 801 0S8 B S 2 FT #HET 106 562 GLU B 5 801 0S8 B B 4 FT #HET 107 563 TYR B 5 801 0S8 B A 5 FT #HET 108 564 ALA B 5 801 0S8 B A 7 FT #HET 109 565 SER B 5 801 0S8 B B 2 FT #HET 111 567 GLY B 5 801 0S8 B B 2 FT #HET 171 627 ARG B 5 801 0S8 B B 1 FT #HET 172 628 ASN B 5 801 0S8 B S 1 FT #HET 174 630 LEU B 5 801 0S8 B S 6 FT #HET 184 640 ALA B 6 802 EDO B A 3 FT #HET 185 641 ASP B 5 801 0S8 B S 1 FT #HET 185 641 ASP B 6 802 EDO B B 8 FT #HET 186 642 PHE B 6 802 EDO B A 7 FT #HET 187 643 GLY B 6 802 EDO B B 3 FT #HET 228 684 TRP B 7 803 EDO B S 3 FT #HET 245 701 TYR B 7 803 EDO B S 4 FT #HET 261 717 HIS B 7 803 EDO B B 1 FT #HET 262 718 ARG B 7 803 EDO B A 4 FT #HET 263 719 MET B 7 803 EDO B A 6 FT #HET 281 737 TRP B 7 803 EDO B S 6 FT DISORDER 1 4 FT DISORDER 45 48 FT DISORDER 122 137 FT DISORDER 190 195 FT DISORDER 201 203 FT DISORDER 306 309 CC SEQUENCE 272 AA (ATOM); CC SEYELPEDPR WELPRDRLVL GKPLGEGAFG QVVLAEAIGL PNRVTKVAVK MLKSDATEKD CC LSDLISEMEM MKMIGKHKNI INLLGACTQD GPLYVIVEYA SKGNLREYLQ ARRQLSSKDL CC VSCAYQVARG MEYLASKKCI HRDLAARNVL VTEDNVMKIA DFGLADYYKK GRLPVKWMAP CC EALFDRIYTH QSDVWSFGVL LWEIFTLGGS PYPGVPVEEL FKLLKEGHRM DKPSNCTNEL CC YMMMRDCWHA VPSQRPTFKQ LVEDLDRIVA LT CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN CC ATOM ----SEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGL----PN CC **************************************** ** CC SEQRES RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP CC ATOM RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP CC ************************************************** CC SEQRES LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ CC ATOM LYVIVEYASKGNLREYLQARR----------------QLSSKDLVSCAYQ CC ********************* ************* CC SEQRES VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK CC ATOM VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------DYYKK CC *************************************** ***** CC SEQRES TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV CC ATOM ---GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV CC *********************************************** CC SEQRES EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR CC ATOM EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR CC ************************************************** CC SEQRES IVALTSNQE CC ATOM IVALT---- CC ***** SQ SEQUENCE 309 AA; MW; CN; GAGVSEYELP EDPRWELPRD RLVLGKPLGE GAFGQVVLAE AIGLDKDKPN RVTKVAVKML KSDATEKDLS DLISEMEMMK MIGKHKNIIN LLGACTQDGP LYVIVEYASK GNLREYLQAR RPPGLEYSYN PSHNPEEQLS SKDLVSCAYQ VARGMEYLAS KKCIHRDLAA RNVLVTEDNV MKIADFGLAR DIHHIDYYKK TTNGRLPVKW MAPEALFDRI YTHQSDVWSF GVLLWEIFTL GGSPYPGVPV EELFKLLKEG HRMDKPSNCT NELYMMMRDC WHAVPSQRPT FKQLVEDLDR IVALTSNQE //